SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-108111
Filing Date
2022-10-12
Accepted
2022-10-12 16:41:07
Documents
1
Period of Report
2022-10-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2226828d4_def14a.htm DEF 14A 334081
  Complete submission text file 0001104659-22-108111.txt   335059
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: DEF 14A | Act: 34 | File No.: 001-39650 | Film No.: 221307218
SIC: 6770 Blank Checks